These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38184511)

  • 1. Arsenic-induced prostate cancer: an enigma.
    Mukherjee AG; Gopalakrishnan AV
    Med Oncol; 2024 Jan; 41(2):50. PubMed ID: 38184511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic arsenic and human prostate cancer.
    Benbrahim-Tallaa L; Waalkes MP
    Environ Health Perspect; 2008 Feb; 116(2):158-64. PubMed ID: 18288312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained Early Disruption of Mitochondrial Function Contributes to Arsenic-Induced Prostate Tumorigenesis.
    Singh B; Kulawiec M; Owens KM; Singh A; Singh KK
    Biochemistry (Mosc); 2016 Oct; 81(10):1089-1100. PubMed ID: 27908234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.
    Ngalame NN; Makia NL; Waalkes MP; Tokar EJ
    Toxicol Appl Pharmacol; 2016 Dec; 312():11-18. PubMed ID: 26721309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
    Benbrahim-Tallaa L; Webber MM; Waalkes MP
    Environ Health Perspect; 2005 Sep; 113(9):1134-9. PubMed ID: 16140617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development.
    Zimta AA; Schitcu V; Gurzau E; Stavaru C; Manda G; Szedlacsek S; Berindan-Neagoe I
    Environ Res; 2019 Nov; 178():108700. PubMed ID: 31520827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.
    Ngalame NN; Tokar EJ; Person RJ; Waalkes MP
    Toxicol Sci; 2014 Dec; 142(2):489-96. PubMed ID: 25273566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium arsenite does not affect prostate carcinogenesis in a chemically-hormonally-induced rat model.
    Bosland MC; Horton L
    Toxicology; 2022 May; 474():153212. PubMed ID: 35598691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa.
    Roh T; Lynch CF; Weyer P; Wang K; Kelly KM; Ludewig G
    Environ Res; 2017 Nov; 159():338-343. PubMed ID: 28841521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.
    Zhou Q; Xi S
    Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic carcinogenesis in the skin.
    Yu HS; Liao WT; Chai CY
    J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation.
    Waalkes MP; Liu J; Ward JM; Diwan BA
    Toxicology; 2004 May; 198(1-3):31-8. PubMed ID: 15138027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic in drinking water and prostate cancer in Illinois counties: An ecologic study.
    Bulka CM; Jones RM; Turyk ME; Stayner LT; Argos M
    Environ Res; 2016 Jul; 148():450-456. PubMed ID: 27136670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.
    Tokar EJ; Diwan BA; Waalkes MP
    Environ Health Perspect; 2010 Jan; 118(1):108-15. PubMed ID: 20056578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
    Waalkes MP; Liu J; Ward JM; Diwan BA
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):377-84. PubMed ID: 15276417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of arsenic toxicity, speciation and polyadenylation of canonical histones.
    Costa M
    Toxicol Appl Pharmacol; 2019 Jul; 375():1-4. PubMed ID: 31077704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.
    Cardoso APF; Al-Eryani L; States JC
    Toxicol Sci; 2018 Oct; 165(2):284-290. PubMed ID: 29846715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic exposure to arsenic causes increased cell survival, DNA damage, and increased expression of mitochondrial transcription factor A (mtTFA) in human prostate epithelial cells.
    Singh KP; Kumari R; Treas J; DuMond JW
    Chem Res Toxicol; 2011 Mar; 24(3):340-9. PubMed ID: 21235219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enigma of arsenic carcinogenesis: role of metabolism.
    Goering PL; Aposhian HV; Mass MJ; Cebrián M; Beck BD; Waalkes MP
    Toxicol Sci; 1999 May; 49(1):5-14. PubMed ID: 10367337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype.
    Xu Y; Tokar EJ; Sun Y; Waalkes MP
    Environ Health Perspect; 2012 Jun; 120(6):865-71. PubMed ID: 22472196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.